Aiming at a Billion-Dollar Market, Pfizer Doubles Down on Obesity Therapies in China Feb 24, 2026 Life Science
Revenue Highly Dependent on the GLP-1 Track: How Does Lilly Balance Growth and Risk? Feb 9, 2026 Life Science
Biogen’s Financial Report and Outlook Exceed Expectations, Stock Soars Nearly 9% on Friday Feb 6, 2026 Life Science
Amazon Begins Selling Oral Weight-Loss Drug Wegovy, Intensifying Competition in the GLP-1 Retail Market Feb 5, 2026 Life Science
Weight Loss Drug Giant Eli Lilly’s Market Cap Surges Nearly $100 Billion, Accelerating Expansion into New Gene Therapy Sector Feb 4, 2026 Life Science
